Economic analyses of phase III cooperative cancer group clinical trials: are they feasible? (Q53608876)

16 May 2018

title

Economic analyses of phase III cooperative cancer group clinical trials: are they feasible? (English)

1 reference

16 May 2018

main subject

phase III clinical trial

0 references

author name string

Bennett CL

1

1 reference

16 May 2018

Golub R

2

1 reference

16 May 2018

Waters TM

3

1 reference

16 May 2018

Tallman MS

4

1 reference

16 May 2018

Rowe JM

5

1 reference

16 May 2018

publication date

1 January 1997

1 reference

16 May 2018

published in

Cancer Investigation

1 reference

16 May 2018

volume

15

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

227-236

1 reference

16 May 2018

Economic analysis in phase III clinical cancer trials

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909709039720

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909709039720

Treatment of acute myeloid leukemia in elderly patients. A retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909709039720

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909709039720

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909709039720

Acute myeloblastic leukaemia--a model for assessing value for money for new treatment programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909709039720

Economic analyses of clinical trials in cancer: are they helpful to policy makers?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909709039720

Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909709039720

Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909709039720

10.3109/07357909709039720

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018